Neurodevelopment Outcomes in Very-Low-Birth-Weight Infants with Metabolic Bone Disease at 2 Years of Age

Neurodevelopment Outcomes in Very-Low-Birth-Weight Infants with Metabolic Bone Disease at 2 Years of Age

Metabolic bone disease (MBD) predominantly affects preterm infants, particularly very-low-birth-weight (VLBW) infants weighing <1500 g. However, there are limited reports on MBD and neurodevelopmental outcomes. This study aimed to analyze the risk factors for MBD and understand its impact on neur...

Full description

Bibliographic Details
Main Authors: Yu-Wen Chen, Yu-Jun Chang, Lih-Ju Chen, Cheng-Han Lee, Chien-Chou Hsiao, Jia-Yuh Chen, Hsiao-Neng Chen
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Children
Subjects:
metabolic bone disease
neurodevelopmental outcomes
very-low-birth-weight infants
risk factors
Bayley Scales of Infant Development-III
Online Access:https://www.mdpi.com/2227-9067/11/1/76

Internet

https://www.mdpi.com/2227-9067/11/1/76

Similar Items